Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes ...

There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...